Janssen Inc. et Al. v. Pharmascience Inc.
Summary of T-558-22
The following information was obtained from the Federal Court or Federal Court of Appeal websites but is NOT the official version. See links below for the court websites.
Federal Court Type: Patented Medicines (NOC) Regulations [Actions]
Parties and Lawyers:| Party | Firm | Lawyer |
|---|---|---|
| JANSSEN INC | BELMORE NEIDRAUER LLP | WILCOX, PETER |
| JANSSEN PHARMACEUTICA NV | ||
| PHARMASCIENCE INC |
| Name | Number |
|---|---|
| 2655335 | |
| INVEGA SUSTENNA |
Patented Medicine: Paliperidone (Medicinal ingredients are based on automated analysis and should not be relied upon.)
Decisions
| Name | Date | Paragraph |
| Janssen Inc. v. Pharmascience Inc. 2022 FC 1218 | Aug 23, 2022 | ... As stated above, at the motion for summary trial dealing solely with the issue of infringement, Janssen’s action was not dismissed, a finding of infringement was made, and this action has proceeded on the basis Pharmascience’s defence of alleged invalidity of the 335 Patent. The Parties have filed a Joint Statement of Issues: Whether any of the claims of the 335 Patent are invalid on the basis of obviousness, pursuant to section 28.3 of the Patent Act; and Whether any of the claims of the 335 Patent are invalid on the basis of lack of patentable subject matter (i.e. as a method of medical treatment) under section 2 of the Patent Act. ... In conclusion, Pharmascience has not established that the claims of the 335 Patent are invalid on the basis of either obviousness or lack of patentable subject matter (i.e. as a method of medical treatment). ... The Plaintiffs are hereby awarded a lump sum of 25% of all reasonable legal fees plus 100% of all reasonable disbursements and taxes, and any dispute about reasonableness of those fees and disbursements shall be determined by an assessment officer |
| Janssen Inc. v. Pharmascience Inc. 2023 FC 1464 | Nov 2, 2023 | This assessment of costs is related to the Federal Court’s Public Judgment and Reasons (2022 FC 1218) dated August 23, 2022, which stated the following regarding costs (at page 64): 5. Janssen is awarded 25% of reasonable legal fees and 100% of reasonable disbursements, exclusive of any motions for which costs have been fixed including the motion for summary trial in Court file no. T-1441-20, with the following limitations: a) the fees of Dr. Ereshefsky and Dr. Chue are reduced by 25%; b) No fees are awarded for Dr. Gobburu, and costs are awarded to Pharmascience for all reasonable costs thrown away given the last minute failure to call him as a witness at the trial. 6. Within 45 days of receiving this decision, the Parties will endeavour to agree on a reasonable costs quantum in accordance with the foregoing parameters, failing which the costs shall be assessed by an assessment officer in accordance with these reasons and judgment. |
Docket Summary (Google Translate to English)
() 2023-11-02 - TorontoCopy of PUBLIC Reasons for Assessment dated 2-NOV-2023 placed on file on 02-NOV-2023 Original filed on Court File No. T-1441-20
Copy of Certificate of Assessment dated 28-SEP-2023 rendered by Morgan, G. placed on file. Original filed on Court File No. T-1441-20
Copy of CONFIDENTIAL Reasons for Assessment dated 28-SEP-2023 rendered by Morgan, G. placed on file. Original filed on Court File No. T-1441-20
Solicitor's certificate of service on behalf of Scott Beeser confirming service of ID 45 and 46 upon Plaintiff by e-mail on 03-MAR-2023 filed on 03-MAR-2023
Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 03-MAR-2023
CONFIDENTIAL Responding Cost Submissions of Defendant filed on 03-MAR-2023
Letter from Defendant to Garnet Morgan, the Assessment Officer dated 03-MAR-2023 enclosing for filing the Defendant's Confidential Responding Costs Submission Record and Book of Authorities received on 03-MAR-2023
Written directions of assessment officer received from Morgan, G. dated 23-FEB-2023 directing that see attached filed on 23-FEB-2023
Solicitor's certificate of service on behalf of Marian Wolanski confirming service of Doc. # 18 and ID # 41 upon Defendant by email on 13-JAN-2023 filed on 13-JAN-2023
Book of Authorities consisting of 1 volume(s) on behalf of Plaintiffs received on 13-JAN-2023
Plaintiffs Confidential Costs Submissions filed on 13-JAN-2023
****** CANCELLED ****** Copy of Reasons for Judgment rendered by: Locke J.A., Mactavish J.A. and Monaghan J.A. dated November 22, 2022 placed on file on 06-DEC-2022 Original placed on Court File No. A-22-22
****** CANCELLED ****** Copy of Judgment dated 22-NOV-2022 rendered by The Honourable Mr. Justice Locke The Honourable Madam Justice Mactavish The Honourable Madam Justice Monaghan placed on file. Original filed on Court File No. A-22-22
****** CANCELLED ****** Copy of Judgment rendered by Locke J.A., Mactavish J.A., Monaghan J.A. dated November 22,2022 placed on file on 06-DEC-2022 Original placed on Court File No. A-22-22
****** CANCELLED ****** Copy of Judgment dated 22-NOV-2022 rendered by The Honourable Mr. Justice Locke The Honourable Madam Justice Mactavish The Honourable Madam Justice Monaghan placed on file. Original filed on Court File No. A-18-22
Acknowledgment of Receipt received from both parties with respect to the direction of the assessment officer issued on 15-NOV-2022 placed on file on 15-NOV-2022
Written directions of assessment officer received from Morgan, G. dated 15-NOV-2022 directing that 1. the assessment of costs will proceed in writing; (see e-copy...) placed on file on 15-NOV-2022
Letter from plaintiffs dated 07-OCT-2022 advising the parties have not been able to agree on the quantum of costs and will request an assessment of costs by an assessment officer. received on 07-OCT-2022
Copy of Notice of Appeal (Appeal Court File No. A-205-22 ) appealing the Judgment dated August 23, 2022 filed in the Court of Appeal on 03-OCT-2022 on behalf of Defendant placed on file on 11-OCT-2022
Amended Further Amended Protective Order rendered on 16-SEP-2022 by Kevin Aalto, Prothonotary filed on 16-SEP-2022 Matter considered without personal appearance amending Doc 22 on T-1441-20 entered in J. & O. Book, volume 1557 page(s) 52 - 67 Interlocutory Decision copies sent to parties
Covering letter from Defendant dated 12-SEP-2022 concerning Doc. No. 15 placed on file on 12-SEP-2022
Solicitor's certificate of service on behalf of Scott Beeser confirming service of 15 upon Plaintiff by email on 12-SEP-2022 filed on 12-SEP-2022
Motion Record containing the following original document(s): 12 13 14 Number of copies received: 1 on behalf of Defendant filed on 12-SEP-2022
Written Representations contained within a Motion Record on behalf of Defendant concerning Motion in writing Doc. No. 12 filed on 12-SEP-2022
Affidavit of Jennifer Nahornaik sworn on 12-SEP-2022 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 12 with Exhibits a filed on 12-SEP-2022
Notice of Motion contained within a Motion Record on behalf of Defendant in writing to be dealt with in the Toronto local office for for an Order pursuant to rule 8, to extend the deadline to Oct. 27 2022, on consent for the parties to agree on a reasonable costs quantum, per para. 6 of the Judgment(23-Aug-2022) and on a no costs basis. filed on 12-SEP-2022
Acknowledgment of Receipt received from both parties with respect to Doc 11 placed on file on 23-AUG-2022
Reasons for Judgment and Judgment CONFIDENTIAL VERSION dated 23-AUG-2022 rendered by The Honourable Mr. Justice Manson Matter considered with personal appearance The Court's decision is with regard to Trial of the matter Result: CONFIDENTIAL Filed on 23-AUG-2022 copies sent to parties Final Decision Certificate of Judgment entered in J. & O. Book, volume 1553 page(s) 188 - 189
Acknowledgment of Receipt received from all parties with respect to Doc 10 placed on file on 23-AUG-2022
Reasons for Judgment and Judgment PUBLIC VERSION dated 23-AUG-2022 rendered by The Honourable Mr. Justice Manson Matter considered with personal appearance The Court's decision is with regard to Trial of the matter Result: "THIS COURT'S JUDGMENT is that: 1. The claims of the 335 Patent are not obvious, and are valid. 2. The claims of the 335 Patent are not methods of medical treatment, are patentable subject matter, and are valid. 3. The making, constructing, using, or selling of pms-PALIPERIDONE PALMITATE by Pharmascience in accordance with ANDS Nos. 244641 and 251767 will infringe the claims of the 335 Patent. 4. An injunction is granted until the expiry of the 335 Patent on December 17, 2028, restraining Pharmascience, as well as its subsidiary and affiliated companies, officers, directors, employees, agents, licensees, successors, assigns, and any others over whom it exercises lawful authority, from: a. Making, constructing, using or selling pms-PALIPERIDONE PALMITATE in Canada in accordance with ANDS Nos. 244641 and 251767; b. Offering for sale, marketing or having pms-PALIPERIDONE PALMITATE marketed in Canada in accordance with ANDS No. 244641 and 251767; and c. Importing, exporting, distributing or having pms-PALIPERIDONE PALMITATE distributed in Canada in accordance with ANDS Nos. 244641 and 251767. 5. Janssen is awarded 25% of reasonable legal fees and 100% of reasonable disbursements, exclusive of any motions for which costs have been fixed including the motion for summary trial in Court file no. T-1441-20, with the following limitations: a) the fees of Dr. Ereshefsky and Dr. Chue are reduced by 25%; b) No fees are awarded for Dr. Gobburu, and costs are awarded to Pharmascience for all reasonable costs thrown away given the last minute failure to call him as a witness at the trial. 6. Within 45 days of receiving this decision, the Parties will endeavour to agree on a reasonable costs quantum in accordance with the foregoing parameters, failing which the costs shall be assessed by an assessment officer in accordance with these reasons and judgment." Filed on 23-AUG-2022 copies sent to parties Final Decision Certificate of Judgment entered in J. & O. Book, volume 1553 page(s) 184 - 185
Toronto 25-MAY-2022 BEFORE The Honourable Mr. Justice Manson Language: E Before the Court: Trial Management Conference Result of Hearing: 1. Plaintiff will submit Draft Order as a result of the items discussed in TMC agenda. 2. Motion for production is set down before Mr. Aalto Associate Judge on June 8, 2022 at 10am for 3h. Responding Motion Record is due June 3, 2022, Reply (max 3 pages) is due June 5, 2022. 3. Closing written Argument is set at 50 max pages. 4. The trial will proceed by way of hybrid hearing, witnesses may appear via remote. 5. The Etoolkit will be used. 6. The parties may request a further TMC should one be required. held by way of video conference Duration per day: 25-MAY-2022 from 12:00 to 12:33 Courtroom : Toronto (Zoom) Court Registrar: Alice Prodan Gil Total Duration: 33min Appearances: Peter Wilcox / Marian Wolanski / Megan Pocalyuko / Juliette Sakran 416-863-3355 representing Plaintiff Marcus Klee / Scott Beeser / Yaseen Manan / Jessica Sudbury 613-695-5858 representing Defendant Comments: Mr. Aalto, Associate Judge also presided this hearing. Minutes of Hearing entered in Vol. 1079 page(s) 250 - 252 Abstract of Hearing placed on file
Letter from Plaintiffs dated 20-MAY-2022 ...writing on behalf of Janssen and defendant...propose following joint agenda for TMC May 25, 2022... received on 20-MAY-2022
Affidavit of service of Mary Mutchler sworn on 31-MAR-2022 on behalf of Plaintiff confirming service of Doc 8 upon Defendant by electronic service on 31-MAR-2022 filed on 31-MAR-2022
Reply to Defence on behalf of plaintiffs Filed on 31-MAR-2022
Toronto 30-MAR-2022 BEFORE Kevin Aalto, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: parties to exchange questions and answers held by way of Conference Call Duration per day: 30-MAR-2022 from 11:00 to 11:15 Courtroom : Judge's Chambers - Toronto Court Registrar: Shaun Nelson Total Duration: 15min Appearances: Peter Wilcox, Marian Wolanski, and Megan Pocalyuko (416) 863-3355 representing Plaintiff Marcus Klee, Jessica Sudbury, and Scott Beeser (647) 317-6869 representing Defendant Minutes of Hearing entered in Vol. 1076 page(s) 487 - 488 Abstract of Hearing placed on file
Acknowledgment of Receipt received from plaintiffs and defendant via email confirmation with respect to Order (doc 7) placed on file on 31-MAR-2022
Order dated 30-MAR-2022 rendered by Kevin Aalto, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: 1.The trial of T-1441-20 and T-558-22 shall be heard together commencing July 4, 2022 2.The documents produced in T-1441-20 shall be deemed to be produced in T-558-22 3.The examinations for discovery in T-1441-20 shall be deemed to be the examinations for discovery in T-558-22 4.Any additional steps taken in T-1441-20 shall be deemed to be taken in T-558-22 5.The parties are relieved from any obligations to file further documents in T-558-22 6.The evidence in T-1441-20 shall be deemed to be the evidence in T-558-22 7.The amended protective order dated September 20, 2021 that was issued in T-1441-20 shall apply in T-558-22 Filed on 30-MAR-2022 copies sent to parties entered in J. & O. Book, volume 1533 page(s) 234 - 235 Interlocutory Decision
Letter from Defendant dated 29-MAR-2022 to the attn of CMJ Aalto in T-558-22 and T-1441-20...parties agree most efficient of Court's resourses to have action in T-558-22 heard and determined at same time and on same record as action T-1441-20...request Order or direction as follows... received on 29-MAR-2022
Letter from Defendant dated 29-MAR-2022 ...in advance of cmc March 30 in T-558-22...parties agree most efficient to use cmc to address discovery issue arisen between parties in T-1441-20... received on 29-MAR-2022
Letter from Plaintiff dated 22-MAR-2022 providing a status update and dates of availability for a CMC received on 22-MAR-2022
Covering letter from Defendant dated 21-MAR-2022 concerning Doc. Nos. 4 5 6 placed on file on 21-MAR-2022
Consent on behalf of all parties to electronic service of all documents not required to be served personally (see electronic document) with proof of service upon all parties on 21-MAR-2022 filed on 21-MAR-2022
Solicitor's certificate of service on behalf of Marcus Klee confirming service of Doc No. 4: Statement of Defence upon Plaintiffs by email (on consent) on 21-MAR-2022 filed on 21-MAR-2022
Defence filed on 21-MAR-2022
Acknowledgment of Receipt received from Defendant with respect to doc. 1 received at hearing on 15-MAR-2022
Acknowledgment of Receipt received from both parties (by email) with respect to doc 7 placed on file on 15-MAR-2022
Order dated 15-MAR-2022 rendered by Chief Justice Crampton Matter considered without personal appearance The Court's decision is with regard to Motion ex proprio motu Result: IT IS ORDERED purusant to Rule 383 that Prothonotary Kevin R. Aalto is assigned as Case Management Judge in this matter. Filed on 15-MAR-2022 copies sent to parties entered in J. & O. Book, volume 1531 page(s) 81 - 81 Interlocutory Decision
Oral directions received from the Court: Kevin Aalto, Prothonotary dated 15-MAR-2022 directing that The Plaintiffs shall provide a copy of this direction and attachment to the Defendant. The parties shall then, within 7 days thereafter, consult with one another and submit: i)An update as to the status of this proceeding indicating their mutual availability... filed on 15-MAR-2022 Confirmed in writing to the party(ies)
Letter from Plaintiff dated 14-MAR-2022 pursuant to section 6.10(1) of PM(NOC)Regulations asking for the file to be assigned to a CMJ;confirming three other active proceedings before the Court involving the same drug and patent; has not renounced the stay set out in paragraph 7(1)(d) of the regulations received on 14-MAR-2022
Statement of Claim filed on 14-MAR-2022 Tariff other action - $150.00
The official version of the court proceeding information is available from the court websites directly: